| First Author | Mangani D | Year | 2024 |
| Journal | Immunity | Volume | 57 |
| Issue | 11 | Pages | 2565-2582.e6 |
| PubMed ID | 39447575 | Mgi Jnum | J:359107 |
| Mgi Id | MGI:7779476 | Doi | 10.1016/j.immuni.2024.09.017 |
| Citation | Mangani D, et al. (2024) Transcription factor TCF1 binds to RORgammat and orchestrates a regulatory network that determines homeostatic Th17 cell state. Immunity |
| abstractText | T helper (Th) 17 cells encompass a spectrum of cell states, including cells that maintain homeostatic tissue functions and pro-inflammatory cells that can drive autoimmune tissue damage. Identifying regulators that determine Th17 cell states can identify ways to control tissue inflammation and restore homeostasis. Here, we found that interleukin (IL)-23, a cytokine critical for inducing pro-inflammatory Th17 cells, decreased transcription factor T cell factor 1 (TCF1) expression. Conditional deletion of TCF1 in mature T cells increased the pro-inflammatory potential of Th17 cells, even in the absence of IL-23 receptor signaling, and conferred pro-inflammatory potential to homeostatic Th17 cells. Conversely, sustained TCF1 expression decreased pro-inflammatory Th17 potential. Mechanistically, TCF1 bound to RORgammat, thereby interfering with its pro-inflammatory functions, and orchestrated a regulatory network that determined Th17 cell state. Our findings identify TCF1 as a major determinant of Th17 cell state and provide important insight for the development of therapies for Th17-driven inflammatory diseases. |
